Back to RTW INVESTMENTS, LPCRNX
CRNX4 quarters
Position history for RTW INVESTMENTS, LP's holdings in CRINETICS PHARMACEUTICALS IN
RTW INVESTMENTS, LP holds 1.5M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $52.7M as of 2026-Q1. The position was increased (+7.4% shares). CRNX represents 0.5% of RTW INVESTMENTS, LP's portfolio.
Current Value
$52.7M
Current Shares
1.5M
Total Value Change
+$39.3M
Total Shares Change
+984,326
Quarter-by-Quarter History
Other major holders of CRNX: FMR LLC, VANGUARD GROUP INC